Detalhe da pesquisa
1.
Safety, tolerability, and antibody response of active Aß immunotherapy with CAD106 in patients with Alzheimer's disease: randomised, double-blind, placebo-controlled, first-in-human study.
Lancet Neurol
; 11(7): 597-604, 2012 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-22677258
2.
Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056.
Sci Transl Med
; 3(64): 64ra1, 2011 Jan 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-21209411
3.
Translocator protein (18 kD) as target for anxiolytics without benzodiazepine-like side effects.
Science
; 325(5939): 490-3, 2009 Jul 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-19541954